Skip to main content

Table 1 Metabolic and lipid profiles (mean ± SD)

From: Use of rosiglitazone before and after vascular injury in hypercholesterolemic rabbits: Assessment of neointimal formation

  

CG

Group I

Group II

P value

Baseline

TC (mg/dl)

58.62 ± 25.08

50.77 ± 18.39

43.54 ± 14.82

NS

 

HDL-C (mg/dl)

24.23 ± 5.31

23.1 ± 6.12

22.69 ± 6.26

NS *

 

TGC (mg/dl)

79.62 ± 26.64

91.15 ± 32.71

79.85 ± 34.31

NS *

 

Glucose (mg/dl)

121.38 ± 17.43

120.77 ± 19.07

117.92 ± 11.44

NS

Vascular injury

TC (mg/dl)

524.38 ± 258.94

431.77 ± 197.38

318.46 ± 212.86

NS

 

HDL-C (mg/dl)

32.46 ± 19.66

28.77 ± 6.15

50.69 ± 21.91

NS *

 

TGC (mg/dl)

72.77 ± 34.95

71.54 ± 46.54

86.92 ± 56.34

NS *

 

Glucose (mg/dl)

250.23 ± 93.02

274.46 ± 58.45

166.62 ± 38.2

0.001

Sacrifice

TC (mg/dl)

852.46 ± 308.48

702.62 ± 261.53

593.54 ± 219,86

NS

 

HDL-C (mg/dl)

42.62 ± 38.23

25.08 ± 13.93

69.08 ± 19.7

0,001 *

 

TGC (mg/dl)

126.77 ± 85.66

398.08 ± 509.76

277.31 ± 248.14

NS *

 

Glucose (mg/dl)

212.85 ± 73.71

210.92 ± 72.99

233.85 ± 89.65

NS

  1. NS – non significant.
  2. * Kruskal-Wallis